title: Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis.
abstract: Montelukast was effective in treating refractory abdominal and urinary symptoms in a child with systemic mastocytosis.
authors: Department of Allergy and Immunology, Children's Hospital at Westmead, Sydney, Australia.
authors: Paul J
authors: PJ
authors: Turner
authors: Andrew S
authors: AS
authors: Kemp
authors: Maureen
authors: M
authors: Rogers
authors: Sam
authors: S
authors: Mehr
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy; D000085:Acetates / Q000627:therapeutic use*; D000799:Angioedema / Q000188:drug therapy; D017332:Cetirizine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D034721:Mastocytosis, Systemic / Q000175:diagnosis / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use*; D011899:Ranitidine / Q000627:therapeutic use; D013440:Sulfides; D014549:Urinary Incontinence / Q000188:drug therapy
chemical_list: D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; D011899:Ranitidine; D011239:Prednisolone; C093875:montelukast; D004205:Cromolyn Sodium; D017332:Cetirizine